Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Julien Dupouey"'
Autor:
Camille Riff, Axel Le Caloch, Julien Dupouey, Laurent Allanioux, Marc Leone, Olivier Blin, Aurélie Bourgoin, Romain Guilhaumou
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 708 (2022)
Background: Local anesthetic systemic toxicity (LAST) has been reported as a serious complication of local anesthetic (LA) peripheral injection. The signs and symptoms of LAST are highly variable, and the challenge remains to confirm its diagnosis. I
Externí odkaz:
https://doaj.org/article/293d79b4a5204d7aa73bec25d620c81b
Autor:
Guilhaumou, Camille Riff, Axel Le Caloch, Julien Dupouey, Laurent Allanioux, Marc Leone, Olivier Blin, Aurélie Bourgoin, Romain
Publikováno v:
Pharmaceutics; Volume 14; Issue 4; Pages: 708
Background: Local anesthetic systemic toxicity (LAST) has been reported as a serious complication of local anesthetic (LA) peripheral injection. The signs and symptoms of LAST are highly variable, and the challenge remains to confirm its diagnosis. I
Autor:
Amélie Marsot, Romain Guilhaumou, Laurent Allanioux, Amelie Ménard, Julien Dupouey, Olivier Blin
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, Wiley, 2020, 86 (11), pp.2319-2324. ⟨10.1111/bcp.14319⟩
Br J Clin Pharmacol
British Journal of Clinical Pharmacology, Wiley, 2020, 86 (11), pp.2319-2324. ⟨10.1111/bcp.14319⟩
Br J Clin Pharmacol
International audience; For management of osteoarticular infections, rifampicin appears to be the key antibiotic. We aimed to evaluate the actual rifampicin dosing regimens using a population pharmacokinetic model of rifampicin in patients with osteo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e98d7dece971af3161b75558541268
https://hal.archives-ouvertes.fr/hal-03597982
https://hal.archives-ouvertes.fr/hal-03597982
Publikováno v:
Therapies. 72:301-309
Resume L’individualisation des traitements est particulierement delicate, car les medicaments utilises, en particulier les antidepresseurs, presentent de nombreux effets indesirables en lien avec des interruptions de traitement assez frequentes. La
Autor:
Amélie Marsot, David Braunstein, E. Fakra, Xavier Zendjidjian, Viktor K. Jirsa, Romain Guilhaumou, Farid Kheloufi, C Riff, Sylvie Bonin-Guillaume, Olivier Blin, Marc Adida, Maxime Guye, Joëlle Micallef, Quentin Boucherie, Julien Dupouey, Raoul Belzeaux, J.-M. Azorin
Publikováno v:
L'Encéphale
L'Encéphale, 2016, 42 (6), pp.S2-S6. ⟨10.1016/S0013-7006(17)30046-5⟩
L'Encéphale, 2016, 42 (6), pp.S2-S6. ⟨10.1016/S0013-7006(17)30046-5⟩
Clinical trials in psychiatry allow to build the regulatory dossiers for market authorization but also to document the mechanism of action of new drugs, to build pharmacodynamics models, evaluate the treatment effects, propose prognosis, efficacy or
Publikováno v:
Thérapie
Thérapie, EDP Sciences-Depuis 2016, la revue Thérapie n’est plus publiée par EDP Sciences.> Therapies (Elsevier), 2016, 71 (5), pp.483-486. ⟨10.1016/j.therap.2016.03.001⟩
Thérapie, EDP Sciences-Depuis 2016, la revue Thérapie n’est plus publiée par EDP Sciences.> Therapies (Elsevier), 2016, 71 (5), pp.483-486. ⟨10.1016/j.therap.2016.03.001⟩
Severe burned patients present high risk of skins infections, frequently due to Pseudomonas aeruginosa. Impregnated dressings with amikacin or colistin could be a good alternative to obtain effective concentration directly at the infected site. Thera
Publikováno v:
Biomedical Chromatography. 30:2053-2060
Therapeutic drug monitoring of antiepileptic drugs is widely practiced to achieve optimal efficacy and avoid adverse side effects. We describe an ultra-high-performance liquid chromatography tandem mass spectrometry (UHPLC/MS/MS) method developed for
Autor:
Jean-Christophe Corvol, Philippe Truffinet, Denis J. David, Raphaël Gaillard, Anne-Lise Pitel, Sylvia Goni, Lisa Otten, Julien Dupouey, Joëlle Micallef, Régis Bordet, Frédéric Checler, Franck Durif, Marie-Louise Kemel, Pierre-Olivier Fernagut, Olivier Blin, Marie-Christine Perault-Pochat, Carole Azuar
Publikováno v:
Therapies. 71:1-13
Resume L’importance du fardeau medico-social des maladies du systeme nerveux contraste avec les limites de l’arsenal therapeutique disponible et les difficultes pour le developpement de nouvelles approches therapeutiques. Ces echecs sont explique
Autor:
Jacques Taillard, Julien Dupouey, Elisabeth Jouve, Daniel Mestre, Colas N. Authié, Bruno Lacarelle, Romain Truillet, Olivier Rascol, Joëlle Micallef, Olivier Blin, Agnès Daurat, Pierre Philip
Publikováno v:
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2018, ⟨10.1111/fcp.12382⟩
Fundamental and Clinical Pharmacology, Wiley, 2018, 32 (5), pp.558-570. ⟨10.1111/fcp.12382⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2018, 32 (5), pp.558-570. ⟨10.1111/fcp.12382⟩
Fundamental and Clinical Pharmacology, Wiley, 2018, ⟨10.1111/fcp.12382⟩
Fundamental and Clinical Pharmacology, Wiley, 2018, 32 (5), pp.558-570. ⟨10.1111/fcp.12382⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2018, 32 (5), pp.558-570. ⟨10.1111/fcp.12382⟩
Driving experiments in real conditions are considered as a 'gold standard' to evaluate the effects of drugs on driving performance. Several constraints are difficult to manage in these conditions, so driving simulation appears as the best alternative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5397c779283dfb6ee700f316ce2bbea3
https://hal-univ-tlse2.archives-ouvertes.fr/hal-01880788
https://hal-univ-tlse2.archives-ouvertes.fr/hal-01880788
Autor:
Laurie Toullec, Olivier Blin, Amélie Marsot, Coralie Vigne, Julien Dupouey, Romain Guilhaumou, Marc Leone, Laurent Allanioux
Publikováno v:
Thérapie
Thérapie, 2017, 72 (5), pp.587-592. ⟨10.1016/j.therap.2017.02.003⟩
Thérapie, EDP Sciences, 2017, 72 (5), pp.587-592. ⟨10.1016/j.therap.2017.02.003⟩
Thérapie, 2017, 72 (5), pp.587-592. ⟨10.1016/j.therap.2017.02.003⟩
Thérapie, EDP Sciences, 2017, 72 (5), pp.587-592. ⟨10.1016/j.therap.2017.02.003⟩
International audience; beta-lactams therapeutic drug monitoring (TDM) appears as an essential tool to ensure the achievement of pharmacokinetic-pharmacodynamic targets and prevent induced toxicity in intensive care unit patients. Indeed, those patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d9d8509330d01b6331f39a8304d4c3
https://hal.science/hal-01730433
https://hal.science/hal-01730433